SOME MECHANISMS OF INFLAMMATION DEVELOPMENT IN TYPE 2 DIABETES MELLITUS

被引:1
|
作者
Bochkareva, Leyla A. [1 ]
Nedosugova, Ludmila, V [1 ]
Petunina, Nina A. [1 ]
Telnova, Milena E. [1 ]
Goncharova, Ekaterina, V [1 ]
机构
[1] IM Sechenov First Moscow State Med Univ, Moscow, Russia
来源
DIABETES MELLITUS | 2021年 / 24卷 / 04期
关键词
inflammation; type 2 diabetes mellitus; insulin resistance; adipose tissue; macrophages; INSULIN-RECEPTOR; PANCREATIC-ISLETS; PPAR-GAMMA; MACROPHAGES; OBESITY; ADIPOCYTES; METABOLISM; RESISTANCE; SECRETION; IMMUNITY;
D O I
10.14341/DM12746
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Inflammation plays a key role in the development and progression of type 2 diabetes (T2DM), a disease characterized by peripheral insulin resistance and systemic glucolipotoxicity. The main source of inflammation in the early stages of the disease is visceral adipose tissue (VT). Macrophages are innate immune cells that are present in all peripheral tissues, including VT. Violation of the response of VT (MT) macrophages to changes in the microenvironment underlies aberrant inflammation and the development of local and systemic insulin resistance. The inflammatory activation of macrophages is regulated at several levels: stimulation of cell surface receptors, intracellular signaling, transcription, and metabolic levels. Which are activated by the transformation of macrophages along the pro-inflammatory or anti-inflammatory pathways. Such polarization of macrophages in modern immunology is divided into classical anti-inflammatory M1 polarization and alternative anti-inflammatory M2 polarization of macrophages. The M1 / M2 ratio of macrophages in the process of inflammation ensures the resolution of inflammation at different stages of its development. The review considers the main mechanisms involved in VT inflammation and the development of insulin resistance in T2DM, supported with the participation of immunocompetent cells, M1 / M2, as well as growth factors and humoral immunity factors secreted during this process.
引用
收藏
页码:334 / 341
页数:8
相关论文
共 50 条
  • [21] Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus
    Akash, Muhammad Sajid Hamid
    Rehman, Kanwal
    Chen, Shuqing
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2013, 114 (03) : 525 - 531
  • [22] Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
    Marc Foretz
    Bruno Guigas
    Benoit Viollet
    Nature Reviews Endocrinology, 2019, 15 : 569 - 589
  • [23] Molecular mechanisms of insulin resistance in type 2 diabetes mellitus
    Saini, Vandana
    WORLD JOURNAL OF DIABETES, 2010, 1 (03): : 68 - 75
  • [24] Mechanisms Underlying the Comorbidity of Schizophrenia and Type 2 Diabetes Mellitus
    Mizuki, Yutaka
    Sakamoto, Shinji
    Okahisa, Yuko
    Yada, Yuji
    Hashimoto, Nozomu
    Takaki, Manabu
    Yamada, Norihito
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2021, 24 (05): : 367 - 382
  • [25] GENETICS Epigenetic mechanisms underlying type 2 diabetes mellitus
    Hanson, Mark A.
    Godfrey, Keith M.
    Nature Reviews Endocrinology, 2015, 11 (05) : 261 - +
  • [26] Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
    Foretz, Marc
    Guigas, Bruno
    Viollet, Benoit
    NATURE REVIEWS ENDOCRINOLOGY, 2019, 15 (10) : 569 - 589
  • [27] Targeting Mechanisms Linking COPD to Type 2 Diabetes Mellitus
    Cazzola, Mario
    Rogliani, Paola
    Calzetta, Luigino
    lauro, DaviDe
    Page, Clive
    Matera, Maria Gabriella
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2017, 38 (10) : 940 - 951
  • [28] Novel therapies with precision mechanisms for type 2 diabetes mellitus
    Leigh Perreault
    Jay S. Skyler
    Julio Rosenstock
    Nature Reviews Endocrinology, 2021, 17 : 364 - 377
  • [29] Epigenetic mechanisms in the development of type 2 diabetes
    Pinney, Sara E.
    Simmons, Rebecca A.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2010, 21 (04): : 223 - 229
  • [30] The Role of MicroRNA in the Development of Type 2 Diabetes Mellitus
    A. V. Krasnobaeva
    V. A. Dugina
    Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 2024, 18 (Suppl 1) : S61 - S68